Cellebrite DI Ltd.
CLBT
$14.44
-$0.09-0.62%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 18.13% | 18.35% | 17.24% | 26.94% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 18.13% | 18.35% | 17.24% | 26.94% | |
| Cost of Revenue | 11.72% | 8.71% | 18.17% | 20.04% | |
| Gross Profit | 19.37% | 20.32% | 17.06% | 28.19% | |
| SG&A Expenses | 16.69% | 16.63% | 21.17% | 23.21% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 15.74% | 16.26% | 19.62% | 23.66% | |
| Operating Income | 32.31% | 32.27% | 4.84% | 44.13% | |
| Income Before Tax | 32.03% | 194.44% | 261.17% | -3,086.38% | |
| Income Tax Expenses | 697.77% | -26.78% | -72.72% | 632.38% | |
| Earnings from Continuing Operations | 10.34% | 181.79% | 231.56% | -3,286.05% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 10.34% | 181.79% | 231.56% | -3,286.05% | |
| EBIT | 32.31% | 32.27% | 4.84% | 44.13% | |
| EBITDA | 34.10% | 26.86% | 4.77% | 39.04% | |
| EPS Basic | 2.42% | 167.67% | 209.69% | -3,027.14% | |
| Normalized Basic EPS | 25.52% | 185.98% | 234.26% | -- | |
| EPS Diluted | 1.78% | 166.17% | 197.16% | -3,407.67% | |
| Normalized Diluted EPS | 29.82% | 183.09% | 226.70% | -- | |
| Average Basic Shares Outstanding | 5.16% | 20.81% | 19.96% | 8.95% | |
| Average Diluted Shares Outstanding | 1.68% | 25.15% | 27.21% | 2.11% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |